Designed Biologics is pioneering the next generation of precision diagnostics and therapeutics with a specialized focus on high-affinity, nano IgG-like antibodies and custom-engineered peptides. Leveraging cutting-edge AI and high-performance computing, we rapidly generate small peptides (30-75 amino acids) and potent inhibitors that target and deactivate even the most challenging proteins, including those previously considered undruggable.
Our platform guarantees unparalleled specificity, screening candidates against the entire human proteome to eliminate undesired interactions. With a 100% experimental success rate and a typical 50% candidate binding rate, our technology delivers robust solutions across therapeutics, diagnostics, and research.
From ELISA technology for protein quantification to designing multi-target inhibitors, we’re setting new standards in biotechnology. Designed Biologics thrives in bridging advanced science and real-world applications to redefine what's possible in medical science.
Company Details
- Founded
- 2016
- Address
- Toronto, On M5v 3l9, Ca
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://designedbiologics.com/
- Keywords
- IT Consulting.
- HQ
- Toronto, ON
Designed Biologics Inc. Questions
Designed Biologics Inc.'s website is https://designedbiologics.com/
Designed Biologics Inc.'s LinkedIn profile is https://ca.linkedin.com/company/designed-biologics
Designed Biologics Inc.'s industry is
Biotechnology Research
Designed Biologics Inc.'s top competitors are
Nurenyx.ai,
Neurosnap Inc.,
Cyphive Innovations Inc.,
Objective Medical Technologies Inc.,
Lighthouse Outcomes Inc,
Hypoai,
Wellwave,
Dateva - Health Data To Health Insights,
Bensino Engineering & Consulting Firm Inc.,
zeroone Ai.
Designed Biologics Inc.'s categories are Biotechnology Research
Designed Biologics Inc.'s founding year is 2016
